But arguably worse than the screens themselves is the hodgepodge of icons premium carmakers now seem to be obsessed with. I want to avoid sounding like an old fart here. I totally understand that the ...

Penn Presbyterian Medical Center has metal detectors installed at hospital entrances and equipped frontline staffers with wearable buttons to immediately call security officers when they’re in danger.

Advanced Micro Devices has emerged as a worthy competitor and is attracting many of Nvidia's top customers. AMD CEO Lisa Su just gave investors a fresh look at the company's newest AI chips.

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Vyalev combines foscarbidopa, a prodrug of carbidopa, and foslevodopa, a prodrug of levodopa, into a solution for continuous subcutaneous 24-hour infusion. The Food and Drug Administration (FDA ...

Grey and drab — that is what comes to mind when we think of keyboard and mouse. Logitech is hoping to change this with the Pop Icon Keys and Mouse, which have a funky design even if their feature set ...

Private equity (PE) in health care — that is, for-profit ownership by private investors of health care providers and facilities — has grown considerably over the past decade, raising lawmakers’ ...

The strikes, carried out by B-2 Spirit stealth bombers, marked the first-ever use of these advanced aircraft against Houthi targets since the beginning of US involvement in the Yemen conflict.

"For too long, the Parkinson's community has had limited treatment options for advanced disease. Due to the progressive nature of the disease, oral medications are eventually no longer as ...

“For too long, the Parkinson’s community has had limited treatment options for advanced disease. Due to the progressive nature of the disease, oral medications are eventually no longer as effective at ...

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.